Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 26.94
+1.32 (5.15%)
Jun 27, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 1.74 billion as of June 27, 2025. Its market cap has decreased by -46.21% in one year.
Market Cap
1.74B
Enterprise Value
2.51B
Revenue
181.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.94
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 1.74B, an increase of 5,557.02%. That is a compound annual growth rate of 26.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.48B |
| Sectra AB | 65.66B |
| Getinge AB | 50.21B |
| Asker Healthcare Group AB | 41.64B |
| Medicover AB | 37.22B |
| Camurus AB | 35.30B |
| AddLife AB | 22.35B |
| Vimian Group AB | 20.59B |